| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |